The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD)
Autor: | D'Ambrosio, R., Campi, I., Maggioni, M., Perbellini, R., Giammona, E., Stucchi, R., Borghi, M., Degasperi, E., De Silvestri, A., Persani L., Fugazzola, L., Lampertico, P. |
---|---|
Rok vydání: | 2020 |
Předmět: |
Liver Cirrhosis
Male Steatosis endocrine system diseases Peptide Hormones Thyroid Gland Thyroid Function Tests Pathology and Laboratory Medicine Severity of Illness Index Biochemistry Cytopathology Endocrinology Non-alcoholic Fatty Liver Disease Medicine and Health Sciences Thyroid Liver Diseases Histological Techniques Middle Aged Prognosis C-Reactive Proteins Liver Medicine Female Anatomy Research Article Adult endocrine system Histology Endocrine Disorders Science Endocrine System Gastroenterology and Hepatology digestive system Hypothyroidism Humans Thyroid-Stimulating Hormone Aged Retrospective Studies nutritional and metabolic diseases Biology and Life Sciences Proteins Fibrosis digestive system diseases Hormones Fatty Liver Anatomical Pathology Case-Control Studies Follow-Up Studies Developmental Biology |
Zdroj: | PLoS ONE PLoS ONE, Vol 16, Iss 4, p e0249614 (2021) |
ISSN: | 1932-6203 |
Popis: | Background:Data on the role of hypothyroidism in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis are conflicting, although selective Thyroid Hormone Receptor (THR)-β agonists have been identified as potential therapy in patients with non-alcoholic steatohepatitis (NASH). Therefore, we investigated the association between hypothyroidism and NAFLD histological features potentially associated with progressive liver disease. Methods:Between 2014 and 2016, consecutive patients with histologically proven NAFLD and frozen serum available for thyroid function tests assessment were included. NAFLD was staged according to the NAFLD Activity Score (NAS), and fibrosis according to Kleiner. NASH was defined as NAS ≥4, significant fibrosis as F2-F4 and significant steatosis as S2-S3. Thyroid function tests (TFT; TSH, FT3, FT4, rT3), TPO-Ab and Tg-Ab were also assessed. Results:Fifty-two patients were analyzed: median age 54 years, 58% females, LSM 7.8 kPa, 27% diabetics, 14% hypothyroid. At histology, NASH was present in 21 (40%), F2-F4 in 28 (54%) and S2-S3 in 30 (58%) patients. Rates of hypothyroidism were similar independently of the presence of NASH (p = 0.11), significant fibrosis (p = 0.21) or steatosis (p = 0.75). However, hypothyroid patients displayed a higher NAS (p = 0.02) and NASH (p = 0.06) prevalence. At multivariate analysis, TFT were not independently associated with histology. Conclusion:Hypothyroidism was highly prevalent in NAFLD patients, and was associated with increased NAFLD activity, but not with fibrosis and steatosis severity. Thus, thyroid dysfunction might play a direct and/or indirect in the pathogenesis of NAFLD and NASH. |
Databáze: | OpenAIRE |
Externí odkaz: |